mesalamine has been researched along with Carcinoma, Squamous Cell in 3 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Azathioprine (AZA) treatment in transplant or autoimmune patients and subsequent appearance squamous cell carcinomas at various sites, particularly skin and cervix, has shown a close relationship." | 1.38 | [A case of squamous cell carcinoma of the breast in a patient with Crohn's disease taking azathioprine]. ( Cho, JY; Heo, SW; Ju, DU; Kim, EJ; Kim, EY; Oh, HK; Park, KC; Ryu, JI, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kumari, P | 1 |
| Ghosh, S | 2 |
| Acharya, S | 1 |
| Mitra, P | 1 |
| Roy, S | 1 |
| Maji, M | 1 |
| Singh, S | 1 |
| Mukherjee, A | 1 |
| Goldie, SJ | 1 |
| Cottle, DL | 1 |
| Tan, FH | 1 |
| Roslan, S | 1 |
| Srivastava, S | 1 |
| Brady, R | 1 |
| Partridge, DD | 1 |
| Auden, A | 1 |
| Smyth, IM | 1 |
| Jane, SM | 1 |
| Dworkin, S | 1 |
| Darido, C | 1 |
| Park, KC | 1 |
| Ju, DU | 1 |
| Heo, SW | 1 |
| Ryu, JI | 1 |
| Cho, JY | 1 |
| Kim, EJ | 1 |
| Oh, HK | 1 |
| Kim, EY | 1 |
3 other studies available for mesalamine and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Cytotoxic Imidazolyl-Mesalazine Ester-Based Ru(II) Complexes Reduce Expression of Stemness Genes and Induce Differentiation of Oral Squamous Cell Carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Differentiation; Cell Line, Tumor; Head and Ne | 2023 |
Loss of GRHL3 leads to TARC/CCL17-mediated keratinocyte proliferation in the epidermis.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Cell Proliferation; Chemokine CCL17; DNA-Binding Prote | 2018 |
[A case of squamous cell carcinoma of the breast in a patient with Crohn's disease taking azathioprine].
Topics: Adult; Azathioprine; Breast Neoplasms; Carcinoma, Squamous Cell; Colonoscopy; Combined Modality Ther | 2012 |